Seagen Inc.
SGENDelisted Dec 14, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001060736
Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Seagen Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 493 | 4 | 471 | −18 |
| Shares | 160.6M | 1.05M | 161.7M | +2.18M (+1.4%) |
| Value | $22.3B | $145.9M | $25.5B | +$3.37B (+15.2%) |
4 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (44)
Institutions that held Seagen Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (62)
Institutions that held Seagen Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
Not filed for Q2 2021 yet (4)
Institutions that held Seagen Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Waddell & Reed Financial Inc | 982,364 | $136.4M |
| Amundi Asset Management US, Inc. | 63,744 | $8.85M |
| E Fund Management Co., Ltd. | 2,686 | $373.0K |
| OneAscent Wealth Management LLC | 2,171 | $301.0K |